InvestorsHub Logo
Followers 5
Posts 359
Boards Moderated 0
Alias Born 01/10/2019

Re: MrGuru post# 50851

Tuesday, 12/17/2019 7:37:05 PM

Tuesday, December 17, 2019 7:37:05 PM

Post# of 232961
It's fine as long as they don't put a hefty price tag on leronlimab as that Shkreli did with other drugs.

I do trust that they stick with 30-60k for HIV and that a certain price has been negotiated so that the biggest possible number of patients may benefit!



"Shkreli is the former CEO of Turing Pharmaceuticals, which in 2015 raised the price of the drug Daraprim by 5,000%, from $13.50 per dose to $750 (cutting it to a mere $375 for some hospitals, after an outcry). The drug treats infections from toxoplasmosis, which can be fatal in patients also suffering from AIDS."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News